Mechanism of anoxic depolarization in the brain

Last updated

Anoxic depolarization is a progressive and uncontrollable depolarization of neurons during stroke or brain ischemia in which there is an inadequate supply of blood to the brain. [1] Anoxic depolarization is induced by the loss of neuronal selective membrane permeability and the ion gradients across the membrane that are needed to support neuronal activity. Normally, the Na+/K+-ATPase pump maintains the transmembrane gradients of K+ and Na+ ions, but with anoxic brain injury, the supply of energy to drive this pump is lost. [2] The hallmarks of anoxic depolarization are increased concentrations of extracellular K+ ions, intracellular Na+ and Ca2+ ions, and extracellular glutamate and aspartate. Glutamate and aspartate are normally present as the brain's primary excitatory neurotransmitters, but high concentrations activate a number of downstream apoptotic and necrotic pathways. This results in neuronal dysfunction and death. [3]

Contents

Neural signal under normal oxygen uptake

Nerve action potential Blausen 0011 ActionPotential Nerve.png
Nerve action potential

Neurons function in the central nervous system by generating signals from synapses, and this only works in the proper chemical environment. [4] An electrical signal is mediated by the sodium channels and leaky potassium channels in which intracellular K+ ion concentration is higher than its corresponding extracellular concentration, whereas extracellular concentrations of Na+, Ca2+, and Cl− ions are higher than the corresponding intracellular concentrations. This uneven distribution of ions is maintained by the Na+/K+ ATPase pump which actively pumps Na+ out and K+ into the cell in a ratio of 3:2 per ATP used. A neuron has a resting membrane potential of -70mV due to the leaky potassium channels. [5] As a neuron depolarizes due to Na+ ion influx through the sodium channels, the membrane reaches a threshold potential and then fires an all or none action potential, which either propagates down the axon or passes on to the other neurons via several gap junctions that link them. [4]

Illustration of a synapse SynapseSchematic en.svg
Illustration of a synapse

A chemical signal (synaptic transmission) begins with the action potential that propagates down the axon of so-called presynaptic terminal to trigger Ca2+ influx, which causes the synaptic vesicles to fuse and release neurotransmitters, via exocytosis, to the synaptic cleft. [5] [6] Released neurotransmitters then bind their specific neuroreceptors at the postsynaptic membrane, or activate their specific ligand-gated ion channels, to fire an action potential that can be either excitatory or inhibitory, depending on the nature of the ligand-gated ion channel. Neurotransmitters are removed from the synaptic cleft by either enzymatic degradation or re-uptake by the same presynaptic neuron, via endocytosis or specific neurotransmitter transporters. [4]

Brain energy crisis

Stroke onset

Within a few seconds of stroke onset, the brain responds by entering a state of metabolic depression, in which energy consumption is reduced to compensate for the reduction in energy production. Metabolic depression occurs as a result of suppressed synaptic transmission and hyperpolarization.

The suppression of synaptic transmission occurs because the presynaptic impulse temporarily fails to trigger the release of neurotransmitters, which, coupled with the altered ion conductance and a change in postsynaptic neuroreceptors, makes synapses unresponsive to neurotransmitter binding, thereby inhibiting postsynaptic excitation. [5]

Hyperpolarization, on the other hand, is employed to reduce neuronal activity by establishing a high threshold potential for firing across an action potential. This energy-conserving response is due to the continuous inward current of K+ ions, which help maintain the membrane ion gradient until the resistance is broken and anoxic depolarization begins. [5]

Imbalance in ion-homeostasis

Maintaining a balance between the intracellular and extracellular ionic concentrations at the postsynaptic terminal is critical to normal neuronal function. During oxygen depletion to the brain, two events that initiate, as well as propagate, anoxic depolarization involve excessive cationic influxes, as well as the outflow of ATP, at the postsynaptic terminal. [1] The receptors that allow this influx and outflow are the ionotropic receptors, which are ligand-gated ion channels that bind specific neurotransmitters, released from the synaptic vesicles of the presynaptic terminal, to trigger the opening of the channels, which serve as conduits for cations that, in turn, initiate action potential across the post synaptic terminals of normally functioning neurons. [7]

The key player in the dramatic process of cationic influx is glutamate, an excitatory neurotransmitter that triggers excitotoxicity during anoxic depolarization. [8] A number of ionotropic receptors have been identified as contributing to anoxic depolarization of nerve cell membranes. They include the NMDA receptors, AMPA receptors, P2X7 purinergic receptors, pannexin channels (Panx1), transient receptor potential (TRP) channels, and acid-sensing ion channels (ASICs). [1]

During brain ischemia, glutamate is released in excess from the presynaptic terminal, leading to the uncontrollable opening of the glutamate receptors, including the NMDA and AMPA receptors, which allows for an excessive influx of Ca2+ into the intracellular environment. Purinergic and NMDA receptors activate the pannexin-1 channels, which become hyperactive and allow the release of ATP from the intracellular environment. As the extracellular glutamate and ATP increase, several complexes are activated and converge into apoptotic and necrotic cascade pathways, which cause neuronal damage and death. [1]

Post-anoxic depolarization: downstream neuronal damage

Low Ca2+ buffering and excitotoxicity under physiological stress and pathophysiological conditions in motor neuron (MNs) Low Ca2+ buffering and excitotoxicity under physiological stress and pathophysiological conditions in motor neuron (MNs).jpg
Low Ca2+ buffering and excitotoxicity under physiological stress and pathophysiological conditions in motor neuron (MNs)

In the aftermath of anoxic depolarization, at the region of infarction, the release of glutamate and aspartate into the extracellular space causes an uncontrollable intracellular mobilization of Ca2+, mainly through the NMDA receptors. [9] This is a critical stage in the development of neuronal damage, because it is the Ca2+ overload that gives rise to several downstream cascades of events that lead to necrotic neuronal death, or to apoptosis, including free radical and nitric oxide productions that cause damage to the membrane. [10]

Another cytotoxic event that follows anoxic depolarization is lactate accumulation and acidosis as a result of glycolysis, which causes damage to the mitochondria. [10] Ischemic insult also causes blood-brain barrier disruption. [9] Other consequential damage that occurs includes lipolysis, proteolysis, cell swelling, microtubule disaggregation, and DNA fragmentation. [5]

Selective vulnerability

Neurons are more susceptible to brain ischemia than the supporting glial cells, because neurons have higher energy demand, conduct an action potential, and produce glutamate, whereas glial cells lack those properties. Yet neurons differ among themselves in their sensitivity to ischemia, depending on the specific properties they exhibit, relating to their locations in the brain. [11]

Selective vulnerability is how some parts of the brain are more sensitive to anoxia than others, and thus to ischemic insult. [10] Anoxia-prone cells in the brain include the hippocampal pyramidal cells of CA1, cerebellar purkinje cells, pyramidal neocortical neurons in some layers, basal ganglia, reticular neurons of the thalamus, and brainstem neurons. [12]

While basal ganglia, cerebellar purkinje cells, hippocampal, and neocortical cells are more vulnerable to transient ischemic attack (TIA), brainstem and thalamic reticular neurons are more vulnerable to prolonged ischemic attack (stroke proper). [11] Meanwhile, the hippocampal pyramidal cells have been identified as the most vulnerable cells to ischemia. [12] One possible explanation for why selective vulnerability exists attributes the phenomenon to the different amounts of glutamate produced by different neurons, since it is glutamate release to the synaptic cleft that triggers Ca2+ influx, which in turn triggers biochemical processes that damage the neurons. [11] In other research, variation in the expression of immediate early gene and heat shock protein was identified as causing selective vulnerability. [12]

Anoxic-tolerance mechanisms

Metabolic depression

The painted turtle (Chrysemys picta) uses the mechanism of metabolic depression to combat oxygen depletion. [13] Within a few minutes of anoxia onset in the turtle's brain there is decreased cerebral blood flow that eventually ceases. Meanwhile, glycolysis is stimulated to maintain a near optimum ATP production. [3] This compensatory stimulation of glycolysis occurs because, in the turtle's brain, cytochrome a and a3 have a low affinity for oxygen. [13] Anaerobic glycolysis leads to lactate overload, which the turtle buffers to some extent by increased shell and bone CaCO3 production. [3]

However, glycolysis is not efficient for ATP production, and in order to maintain an optimum ATP concentration, the turtle's brain reduces its ATP consumption by suppressing its neuronal activity and gradually releasing adenosine. This re-establishes the ATP consumption/production balance, which is then maintained by reducing ion conductance and releasing GABA. The decrease in neuronal activity renders the turtle comatose for the duration of anoxia. [14]

Pasteur effect

Another anoxia-tolerant animal that is commonly used as a model to study anoxia in the mammalian brain is the crucian carp, which can survive at even more extreme anoxic conditions than the painted turtle can. Unlike C. picta, which takes such drastic measures in becoming comatose to maintain an optimum ATP concentration, the crucian carp does not become comatose in anoxia. Instead, it stays active by maintaining its normal cardial output as well as increasing its cerebral blood flow. [5] Even though glycolysis is stimulated early in anoxia in both the crucian carp and C. picta, the crucian carp is able to stay active because of its capability to re-route the glycolytic pathway such that lactate is converted into ethanol, which can then be released into the water via the gills, thus preventing lactate overload and acidosis. [3]

Since the crucian carp has a more efficient strategy to prevent lactate buildup than C. picta, the initial glycolysis continues without ceasing, a process called the Pasteur effect. [14] In order to keep up with this fast glucose metabolism via glycolysis, as well as maintain the balance between ATP production and consumption, the crucian carp moderately suppresses its motor activities, releases GABA, and selectively suppresses some unnecessary sensory functions. [14] Crucian carp also counteracts the damaging effects of anoxia by swimming into cooler water, a phenomenon known as voluntary hypothermia. [3]

Tolerance in mammalian neonates

The brains of several mammalian neonates have been identified as able to confer resistance to anoxia in a fashion similar to that of the anoxic-tolerant aquatic organisms. [13] This is still a relatively new area of study that could have a clinical significance in combating stroke in humans. A study that looked into anoxic-tolerance in newborn mammals identified two main ways in which they cope with acute hypoxia. While most newborns, preferentially, depress their metabolic rate to conserve energy during anoxia, some mammalian newborns—such as the pig, the deer, and other animals in their class, which are capable of a high degree of independent activity from birth—employ hyperpnoea (abnormally rapid or deep breathing). [15] Why metabolic depression is less effective in adult mammals, compared to neonates, is unclear at the moment. Due to ethical issues, anoxic-tolerance has not been tested in human neonates.

Research: neuroprotective agents

NMDA receptor activation and antagonists NMDA receptor activation and antagonists.PNG
NMDA receptor activation and antagonists

Currently, there is no effective way to combat stroke. The only FDA-approved drug to treat stroke is a clot-dissolving, genetically-engineered enzyme called tissue plasminogen activator, which must be administered within 9 hours of the onset of symptoms, in order to be effective in reducing damage following ischemic stroke. [16]

Many clinical trials have failed in an attempt to develop effective neuroprotective drugs to combat stroke, perhaps because those drugs only deal with one aspect of stroke, and therefore neglect the fact that stroke is a multifaceted problem. Some of the potential treatments for stroke that have been tested by a number of researchers, using several animal models, involve sigma-1 receptor ligands, to modulate Ca2+ release, NMDA receptor antagonists, to prevent Ca2+ overload, and ion channel blockers, to prevent excessive ion fluxes.[ citation needed ]

See also

Related Research Articles

<span class="mw-page-title-main">Neuron</span> Electrically excitable cell that communicates via synapses

A neuron, neurone, or nerve cell is an electrically excitable cell that communicates with other cells via synapses - specialized connections that commonly use minute amounts of neurotransmitters to pass the electric signal from the presynaptic neuron to the target cell through the synaptic gap. The neuron is the main component of nervous tissue in all animals except sponges and placozoa. Non-animals like plants and fungi do not have nerve cells.

<span class="mw-page-title-main">Neurotransmitter receptor</span> Type of protein

A neurotransmitter receptor is a membrane receptor protein that is activated by a neurotransmitter. Chemicals on the outside of the cell, such as a neurotransmitter, can bump into the cell's membrane, in which there are receptors. If a neurotransmitter bumps into its corresponding receptor, they will bind and can trigger other events to occur inside the cell. Therefore, a membrane receptor is part of the molecular machinery that allows cells to communicate with one another. A neurotransmitter receptor is a class of receptors that specifically binds with neurotransmitters as opposed to other molecules.

<span class="mw-page-title-main">NMDA receptor</span> Glutamate receptor and ion channel protein found in nerve cells

The N-methyl-D-aspartatereceptor (also known as the NMDA receptor or NMDAR), is a glutamate receptor and ion channel found in neurons. The NMDA receptor is one of three types of ionotropic glutamate receptors, the other two being AMPA and kainate receptors. Depending on its subunit composition, its ligands are glutamate and glycine (or D-serine). However, the binding of the ligands is typically not sufficient to open the channel as it may be blocked by Mg2+ ions which are only removed when the neuron is sufficiently depolarized. Thus, the channel acts as a “coincidence detector” and only once both of these conditions are met, the channel opens and it allows positively charged ions (cations) to flow through the cell membrane. The NMDA receptor is thought to be very important for controlling synaptic plasticity and mediating learning and memory functions.

In neuroscience, synaptic plasticity is the ability of synapses to strengthen or weaken over time, in response to increases or decreases in their activity. Since memories are postulated to be represented by vastly interconnected neural circuits in the brain, synaptic plasticity is one of the important neurochemical foundations of learning and memory.

An inhibitory postsynaptic potential (IPSP) is a kind of synaptic potential that makes a postsynaptic neuron less likely to generate an action potential. IPSP were first investigated in motorneurons by David P. C. Lloyd, John Eccles and Rodolfo Llinás in the 1950s and 1960s. The opposite of an inhibitory postsynaptic potential is an excitatory postsynaptic potential (EPSP), which is a synaptic potential that makes a postsynaptic neuron more likely to generate an action potential. IPSPs can take place at all chemical synapses, which use the secretion of neurotransmitters to create cell to cell signalling. Inhibitory presynaptic neurons release neurotransmitters that then bind to the postsynaptic receptors; this induces a change in the permeability of the postsynaptic neuronal membrane to particular ions. An electric current that changes the postsynaptic membrane potential to create a more negative postsynaptic potential is generated, i.e. the postsynaptic membrane potential becomes more negative than the resting membrane potential, and this is called hyperpolarisation. To generate an action potential, the postsynaptic membrane must depolarize—the membrane potential must reach a voltage threshold more positive than the resting membrane potential. Therefore, hyperpolarisation of the postsynaptic membrane makes it less likely for depolarisation to sufficiently occur to generate an action potential in the postsynaptic neurone.

<span class="mw-page-title-main">Excitatory postsynaptic potential</span> Process causing temporary increase in postsynaptic potential

In neuroscience, an excitatory postsynaptic potential (EPSP) is a postsynaptic potential that makes the postsynaptic neuron more likely to fire an action potential. This temporary depolarization of postsynaptic membrane potential, caused by the flow of positively charged ions into the postsynaptic cell, is a result of opening ligand-gated ion channels. These are the opposite of inhibitory postsynaptic potentials (IPSPs), which usually result from the flow of negative ions into the cell or positive ions out of the cell. EPSPs can also result from a decrease in outgoing positive charges, while IPSPs are sometimes caused by an increase in positive charge outflow. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC).

In neuroscience, a silent synapse is an excitatory glutamatergic synapse whose postsynaptic membrane contains NMDA-type glutamate receptors but no AMPA-type glutamate receptors. These synapses are named "silent" because normal AMPA receptor-mediated signaling is not present, rendering the synapse inactive under typical conditions. Silent synapses are typically considered to be immature glutamatergic synapses. As the brain matures, the relative number of silent synapses decreases. However, recent research on hippocampal silent synapses shows that while they may indeed be a developmental landmark in the formation of a synapse, that synapses can be "silenced" by activity, even once they have acquired AMPA receptors. Thus, silence may be a state that synapses can visit many times during their lifetimes.

<span class="mw-page-title-main">Excitatory synapse</span> Sort of synapse

An excitatory synapse is a synapse in which an action potential in a presynaptic neuron increases the probability of an action potential occurring in a postsynaptic cell. Neurons form networks through which nerve impulses travel, each neuron often making numerous connections with other cells. These electrical signals may be excitatory or inhibitory, and, if the total of excitatory influences exceeds that of the inhibitory influences, the neuron will generate a new action potential at its axon hillock, thus transmitting the information to yet another cell.

<span class="mw-page-title-main">Excitotoxicity</span> Process that kills nerve cells

In excitotoxicity, nerve cells suffer damage or death when the levels of otherwise necessary and safe neurotransmitters such as glutamate become pathologically high, resulting in excessive stimulation of receptors. For example, when glutamate receptors such as the NMDA receptor or AMPA receptor encounter excessive levels of the excitatory neurotransmitter, glutamate, significant neuronal damage might ensue. Excess glutamate allows high levels of calcium ions (Ca2+) to enter the cell. Ca2+ influx into cells activates a number of enzymes, including phospholipases, endonucleases, and proteases such as calpain. These enzymes go on to damage cell structures such as components of the cytoskeleton, membrane, and DNA. In evolved, complex adaptive systems such as biological life it must be understood that mechanisms are rarely, if ever, simplistically direct. For example, NMDA in subtoxic amounts induces neuronal survival of otherwise toxic levels of glutamate.

Synaptogenesis is the formation of synapses between neurons in the nervous system. Although it occurs throughout a healthy person's lifespan, an explosion of synapse formation occurs during early brain development, known as exuberant synaptogenesis. Synaptogenesis is particularly important during an individual's critical period, during which there is a certain degree of synaptic pruning due to competition for neural growth factors by neurons and synapses. Processes that are not used, or inhibited during their critical period will fail to develop normally later on in life.

<span class="mw-page-title-main">Ligand-gated ion channel</span> Type of ion channel transmembrane protein

Ligand-gated ion channels (LICs, LGIC), also commonly referred to as ionotropic receptors, are a group of transmembrane ion-channel proteins which open to allow ions such as Na+, K+, Ca2+, and/or Cl− to pass through the membrane in response to the binding of a chemical messenger (i.e. a ligand), such as a neurotransmitter.

Molecular neuroscience is a branch of neuroscience that observes concepts in molecular biology applied to the nervous systems of animals. The scope of this subject covers topics such as molecular neuroanatomy, mechanisms of molecular signaling in the nervous system, the effects of genetics and epigenetics on neuronal development, and the molecular basis for neuroplasticity and neurodegenerative diseases. As with molecular biology, molecular neuroscience is a relatively new field that is considerably dynamic.

<span class="mw-page-title-main">Glutamate receptor</span> Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells

Glutamate receptors are synaptic and non synaptic receptors located primarily on the membranes of neuronal and glial cells. Glutamate is abundant in the human body, but particularly in the nervous system and especially prominent in the human brain where it is the body's most prominent neurotransmitter, the brain's main excitatory neurotransmitter, and also the precursor for GABA, the brain's main inhibitory neurotransmitter. Glutamate receptors are responsible for the glutamate-mediated postsynaptic excitation of neural cells, and are important for neural communication, memory formation, learning, and regulation.

The ischemic (ischaemic) cascade is a series of biochemical reactions that are initiated in the brain and other aerobic tissues after seconds to minutes of ischemia. This is typically secondary to stroke, injury, or cardiac arrest due to heart attack. Most ischemic neurons that die do so due to the activation of chemicals produced during and after ischemia. The ischemic cascade usually goes on for two to three hours but can last for days, even after normal blood flow returns.

Gliotransmitters are chemicals released from glial cells that facilitate neuronal communication between neurons and other glial cells. They are usually induced from Ca2+ signaling, although recent research has questioned the role of Ca2+ in gliotransmitters and may require a revision of the relevance of gliotransmitters in neuronal signalling in general.

<span class="mw-page-title-main">Chloride potassium symporter 5</span> Protein-coding gene in the species Homo sapiens

Potassium-chloride transporter member 5 is a neuron-specific chloride potassium symporter responsible for establishing the chloride ion gradient in neurons through the maintenance of low intracellular chloride concentrations. It is a critical mediator of synaptic inhibition, cellular protection against excitotoxicity and may also act as a modulator of neuroplasticity. Potassium-chloride transporter member 5 is also known by the names: KCC2 for its ionic substrates, and SLC12A5 for its genetic origin from the SLC12A5 gene in humans.

<span class="mw-page-title-main">Eliprodil</span> Chemical compound

Eliprodil is an NMDA antagonist drug candidate which selectively inhibits the NR2B (GLUN2B) subtype NMDA receptor at submicromolar concentrations. Eliprodil failed a Phase III clinical trial for the treatment of acute ischemic stroke in 1996, sponsored by Synthélabo Recherche.

<span class="mw-page-title-main">Dendritic spike</span> Action potential generated in the dendrite of a neuron

In neurophysiology, a dendritic spike refers to an action potential generated in the dendrite of a neuron. Dendrites are branched extensions of a neuron. They receive electrical signals emitted from projecting neurons and transfer these signals to the cell body, or soma. Dendritic signaling has traditionally been viewed as a passive mode of electrical signaling. Unlike its axon counterpart which can generate signals through action potentials, dendrites were believed to only have the ability to propagate electrical signals by physical means: changes in conductance, length, cross sectional area, etc. However, the existence of dendritic spikes was proposed and demonstrated by W. Alden Spencer, Eric Kandel, Rodolfo Llinás and coworkers in the 1960s and a large body of evidence now makes it clear that dendrites are active neuronal structures. Dendrites contain voltage-gated ion channels giving them the ability to generate action potentials. Dendritic spikes have been recorded in numerous types of neurons in the brain and are thought to have great implications in neuronal communication, memory, and learning. They are one of the major factors in long-term potentiation.

<span class="mw-page-title-main">Nonsynaptic plasticity</span> Form of neuroplasticity

Nonsynaptic plasticity is a form of neuroplasticity that involves modification of ion channel function in the axon, dendrites, and cell body that results in specific changes in the integration of excitatory postsynaptic potentials and inhibitory postsynaptic potentials. Nonsynaptic plasticity is a modification of the intrinsic excitability of the neuron. It interacts with synaptic plasticity, but it is considered a separate entity from synaptic plasticity. Intrinsic modification of the electrical properties of neurons plays a role in many aspects of plasticity from homeostatic plasticity to learning and memory itself. Nonsynaptic plasticity affects synaptic integration, subthreshold propagation, spike generation, and other fundamental mechanisms of neurons at the cellular level. These individual neuronal alterations can result in changes in higher brain function, especially learning and memory. However, as an emerging field in neuroscience, much of the knowledge about nonsynaptic plasticity is uncertain and still requires further investigation to better define its role in brain function and behavior.

<span class="mw-page-title-main">Glutamate (neurotransmitter)</span> Anion of glutamic acid in its role as a neurotransmitter

In neuroscience, glutamate refers to the anion of glutamic acid in its role as a neurotransmitter: a chemical that nerve cells use to send signals to other cells. It is by a wide margin the most abundant excitatory neurotransmitter in the vertebrate nervous system. It is used by every major excitatory function in the vertebrate brain, accounting in total for well over 90% of the synaptic connections in the human brain. It also serves as the primary neurotransmitter for some localized brain regions, such as cerebellum granule cells.

References

  1. 1 2 3 4 Weilinger NL, Maslieieva V, Bialecki J, Sridharan SS, Tang PL, Thompson RJ (2013). "Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction". Acta Pharmacol Sin. 34 (1): 39–48. doi:10.1038/aps.2012.95. PMC   4086487 . PMID   22864302.
  2. ↑ Stys, P. (1998). "Anoxic and ischemic injury of myelinated axons in CNS white matter: from Mechanistic Concepts to Therapeutics". Journal of Cerebral Blood Flow and Metabolism. 18 (1): 2–25. doi: 10.1097/00004647-199801000-00002 . PMID   9428302.
  3. 1 2 3 4 5 Nilsson, G.; Lutz, P (2004). "Anoxia tolerant brains". Journal of Cerebral Blood Flow and Metabolism. 24 (5): 475–486. doi: 10.1097/00004647-200405000-00001 . PMID   15129179.
  4. 1 2 3 Purves, Dale; Augustine, G. J.; Fitzpatrick, D.; Hall, W. C.; LaMantia, A.; McNamara, J. O.; White, L. E. (2008). "Neural Signaling". Neuroscience (4th ed.). Sunderland, MA: Sinauer. pp.  23–207. ISBN   9780878936977.
  5. 1 2 3 4 5 6 Lutz, P. L.; Nilsson, G. E. (1997). Neuroscience intelligence unit: The Brain Without Oxygen (2nd ed.). Austin, TX: Landes Bioscience and Chapman & Hall. pp. 1–207.
  6. ↑ Kochlamazashvili, G; Haucke, V (2013). "A dual role of SNAP-25 as carrier and guardian of synaptic transmission". EMBO Reports. 14 (7): 579–580. doi:10.1038/embor.2013.74. PMC   3701241 . PMID   23732543.
  7. ↑ Goyal, R; Chaudhury, A (2013). "Structure activity relationship of synaptic and junctional neurotransmission". Autonomic Neuroscience: Basic and Clinical. 176 (1–2): 11–31. doi:10.1016/j.autneu.2013.02.012. PMC   3677731 . PMID   23535140.
  8. ↑ Madry, C; Haglerød, C; Attwell, D (2010). "The role of pannexin hemichannels in the anoxic depolarization of hippocampal pyramidal cells". Brain. 133 (Pt 12): 3755–3763. doi:10.1093/brain/awq284. PMC   2995884 . PMID   20940167.
  9. 1 2 Zhao, H; Steinberg, G.; Sapolsky, R (2007). "General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage". Journal of Cerebral Blood Flow and Metabolism. 27 (12): 1879–1894. doi: 10.1038/sj.jcbfm.9600540 . PMID   17684517.
  10. 1 2 3 Huang, B; Castillo, M (2008). "Hypoxic-ischemic brain injury: imaging findings from birth to adulthood". Radiographics. 28 (2): 417–439. doi:10.1148/rg.282075066. PMID   18349449.
  11. 1 2 3 Agamanolis, D. "Chapter 2: Cerebral Ischemia and Stroke". Neuropathology. Retrieved 4 November 2013.
  12. 1 2 3 Busl, K; Greer, D (2010). "Hypoxic-ischemic brain injury: pathophysiology, neuropathology and mechanisms". NeuroRehabilitation. 26 (1): 5–13. doi: 10.3233/NRE-2010-0531 . PMID   20130351.
  13. 1 2 3 Lutz, P. L (1992). "Mechanisms for Anoxic Survival in the Vertebrate Brain". Annual Review of Physiology. 54: 601–618. doi:10.1146/annurev.ph.54.030192.003125. PMID   1348613.
  14. 1 2 3 John W. Thompson; Göran E. Nilsson; Miguel A. Perez-Pinzon (2013). "2: Anoxia Resistance in Lower and Higher Vertebrates". In Jeffrey M. Gidday; Miguel A. Perez-Pinzon; John H. Zhang (eds.). Innate Tolerance in the CNS: Translational Neuroprotection by Pre- and Post-Conditioning. New York: Springer New York. pp. 19–35. ISBN   978-1-4419-9694-7.
  15. ↑ Mortola, J (1999). "How newborn mammals cope with hypoxia". Respiration Physiology. 116 (2–3): 95–103. doi:10.1016/S0034-5687(99)00038-9. PMID   10487295.
  16. ↑ Behensky, A; Cortes-Salva, M.; Seminerio, M.; Matsumoto, R.; Antilla, J.; Cuevas, J. (2013). "In vitro evaluation of guanidine analogs as sigma receptor ligands for potential anti-stroke therapeutics". The Journal of Pharmacology and Experimental Therapeutics. 344 (1): 155–166. doi:10.1124/jpet.112.199513. PMC   3533416 . PMID   23065135.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.